SAGILITY LIMITED has informed the Exchange regarding a press release dated May 12, 2026, titled "Press release pertaining to audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026".
SAGILITY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sagility Limited reported strong FY26 results with revenue of ₹71,929 million (US$814 million), up 29.1% YoY (23.6% in constant currency). Adjusted EBITDA stood at ₹18,200 million (25.3% margin) with 23.9% growth, while Adjusted PAT grew 39.5% to ₹11,306 million (15.7% margin). For Q4 alone, revenue was ₹20,243 million with 29.1% YoY growth and adjusted EBITDA margin of 24.9%. The company added 17 new clients in FY26 and secured $30.7 million of potential steady-state ACV through new wins and expansions. The CFO highlighted continued deleveraging of the balance sheet and reduction in net debt during the year. Voluntary attrition rose to 38.1% annualized in Q4, up from 22.8% in Q3, though full-year attrition was 29.4% vs 27.5% prior year.
Sagility delivered robust double-digit revenue and profit growth, reflecting strong execution in a challenging U.S. healthcare environment. The 110 bps decline in FY26 adjusted EBITDA margin (25.3% vs 26.4% prior year) shows some margin pressure from growth investments, but the CFO's focus on debt reduction and cash generation signals a balanced approach to capital allocation. The high client concentration risk remains (top 3 clients at ~60% revenue), though it is improving.